Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke.

J Stroke · 2015 · PMC4635722 · PMID 26437998

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the third International Stroke Trial (IST-3) where 53% of 3,035 patients enrolled were aged > 80 years, the benefit of TPA was greater in patients aged > 80 years than in those ≤ 80 years, but the result did not reach statistical significance [ 12 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.